National Research Co. (NASDAQ:NRC) Shares Bought by Algert Global LLC

Algert Global LLC grew its position in National Research Co. (NASDAQ:NRC) by 9.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,739 shares of the company’s stock after purchasing an additional 3,700 shares during the period. Algert Global LLC owned approximately 0.18% of National Research worth $981,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Select Equity Group L.P. increased its position in shares of National Research by 7.3% in the second quarter. Select Equity Group L.P. now owns 35,537 shares of the company’s stock worth $816,000 after acquiring an additional 2,408 shares in the last quarter. Millennium Management LLC boosted its position in National Research by 200.9% during the 2nd quarter. Millennium Management LLC now owns 214,858 shares of the company’s stock worth $4,931,000 after purchasing an additional 143,454 shares during the period. Deerfield Management Company L.P. Series C increased its holdings in National Research by 107.0% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 18,620 shares of the company’s stock valued at $427,000 after purchasing an additional 9,626 shares in the last quarter. AQR Capital Management LLC raised its position in National Research by 18.9% in the second quarter. AQR Capital Management LLC now owns 28,936 shares of the company’s stock valued at $664,000 after purchasing an additional 4,601 shares during the period. Finally, Squarepoint Ops LLC acquired a new position in shares of National Research during the second quarter worth about $845,000. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Price Performance

NRC stock opened at $19.97 on Friday. The firm has a market cap of $476.82 million, a P/E ratio of 16.10 and a beta of 0.48. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.37 and a current ratio of 0.37. National Research Co. has a 1 year low of $19.92 and a 1 year high of $46.87. The stock has a 50-day simple moving average of $22.14 and a 200-day simple moving average of $27.43.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter. The company had revenue of $35.02 million during the quarter. National Research had a net margin of 20.01% and a return on equity of 63.64%.

National Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.40%. The ex-dividend date of this dividend is Friday, September 27th. National Research’s dividend payout ratio (DPR) is 38.71%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.